Video & Transcript Research : 'cannabinoids'

Page 2 of 11
TX

Texas 89th Regular

Senate Session Aug 1st, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Hemp products and the hemp-derived cannabinoids contained in those products.
  • But like them, I support age restrictions on purchases. a ban on synthetic cannabinoids, and I support
  • These synthetic cannabinoids, often chemically altered to evade regulation, pose significant risks to
  • a ban and a TCUP medical program that provides those who can get a better medical benefit from cannabinoids
Bills: SB5, SB11, SB12, SB5, SB11, SB12
TX

Texas 89th 2nd C.S.

Finance Aug 15th, 2025

Finance

Bills: SB2, SB3, SB5, SB9, SB10, SB14, SB16, SB34, SB18
Summary: The Senate Committee on Finance met in the second special session and considered a series of bills, mostly related to flood response, water infrastructure, taxation, school accountability, property fraud, and legislative procedure. Senator Zaffirini presented SB 18 on TCEQ permit exemptions for certain erosion, floodwater, and sediment control dams or reservoirs; Senator Perry presented SB 2 on flood relief preparedness, SB 14 on credit impact fees and water supply/conservation incentives, and SB 5 on Hill Country relief funding; Senator Bettencourt presented SB 3 on early warning flood sirens, SB 9 on replacing STAAR with three annual tests and strengthening A-F accountability, and SB 10 on lowering the rollback tax rate from 3.5% to 2.5%; Senator West presented SB 16 on property transaction ID requirements and new real property theft/fraud offenses; and Chair Huffman laid out SB 34, which changes legislative witness immunity rules from transactional immunity to testimonial immunity consistent with federal law. The committee also heard brief explanations that several bills were the same as versions previously passed by the Senate or committee, and there was limited public testimony, with no witnesses on most bills and only position cards on SB 16. Senator West raised a concern on SB 10 about a possible carve-out for police pay raises, but Senator Bettencourt said no change would be made at that time. For SB 34, Chair Huffman explained the bill would still allow compelled testimony before the legislature but would no longer provide blanket immunity, while preserving the right to counsel. The committee voted favorably on all bills considered. SB 18, SB 2, SB 14, SB 3, SB 16, SB 5, and SB 34 were reported out unanimously or near-unanimously, while SB 9 passed 10-1 and SB 10 passed 8-3. At the end of the meeting, Senator West requested to be shown voting nay on SB 9, and the chair granted unanimous consent. The committee then recessed subject to the call of the chair.
TX

Texas 89th 1st C.S.

Senate Session (Part II) Jul 21st, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Senate Bill 5 by Obama concerns the cannabinoids contained in those products. To State Affairs.
Summary: The meeting centered around the discussion of congressional redistricting, where the committee established the procedures to ensure a fair and transparent process. Led by Senator King, the session focused on adopting a resolution that authorized a special committee dedicated to congressional redistricting and allowed for regional hearings to gather public input via videoconferencing. Concerns were raised about ensuring adequate notice for public participation, especially from marginalized communities potentially affected by proposed changes. Disagreements emerged regarding the timeline for regional hearings and how to address the implications of the redistricting process on minority districts. Overall, participants acknowledged the complex nature of redistricting and the importance of engaging constituents in the legislative process.
HI
Summary: The committee heard testimony on several health-related bills. HB 1864, which would require health insurance coverage for standard fertility preservation services for people undergoing medically necessary treatment, drew broad support from SHIPA, the Department of Health, HMSA, the Hawaii Association of Health Plans, and others. Testifiers emphasized that fertility preservation is routine coverage on the mainland and important for patients facing infertility from cancer or other treatment; one patient described incurring more than $20,000 in costs. The Insurance Division flagged possible Affordable Care Act issues, a potential conflict in the bill’s language about using patient history to determine limits, and a mismatch with state medical-necessity standards. Committee discussion also focused on whether the bill should apply to all women of childbearing age rather than a narrower age-based category. HB 2305 would require nutrition and metabolic education as part of physicians’ continuing medical education. The Hawaii Medical Board opposed the measure, arguing that CME should remain flexible and tailored to each physician’s specialty and warning that topic-specific mandates can expand over time. The Office of the Governor supported the bill, saying it would help the state’s rural health transformation application and could improve federal funding prospects, though the exact impact was unclear. Members questioned whether nutrition is already covered in medical training and whether the requirement should be limited to primary care physicians; the board said Hawaii currently has no topic-specific CME mandates and that physicians can already choose relevant courses. The committee also heard strong support for HB 1597, which would establish an Alzheimer’s disease research center at the University of Hawaii. Supporters from the university, the Alzheimer’s Association, AARP, and others said the center could attract federal research dollars, expand clinical trials, and help address the state’s high Alzheimer’s-related health costs. HB 2159, which appropriates funds for health care workforce development, also received broad support from the University of Hawaii, health systems, and advocacy groups, with no opposition noted. Finally, HB 2121, which would prohibit the sale and distribution of disposable electronic smoking devices, drew support from the Department of Health, youth advocates, and public health groups citing youth addiction, environmental waste, and fire hazards; the department said a separate bill, HB 1573, would be more comprehensive and better defined for enforcement and penalties. The committee ended with HB 1913, creating a veteran services mental health coordinator position at Tripler Army Medical Center, which was supported by veteran services officials and others who said veterans need better navigation and coordination for behavioral health care.
TX

Texas 89th 2nd C.S.

State Affairs Aug 15th, 2025

State Affairs

Transcript Highlights:
  • Under this bill, most of the therapeutic benefits are seen with a healthy mix of cannabinoids, not just
  • has heard on this issue with mothers coming in, they're real, but they all have to do with fake cannabinoids
  • 2011, on average, 7% of all cases reported to the national program on substance abuse deaths had a cannabinoid
  • detected, meaning about 100,000... ...had a cannabinoid detected, meaning about 110 deaths a year had
Bills: SB6, SB7, SB8, SB11, SB12, SB13, SB15, SB17
Summary: The committee first took up Senate Bill 8, the Texas Women's Privacy Act, and heard extensive public testimony both for and against the measure. Supporters, including representatives of Texas Values and Texas Values Action, argued the bill was needed to protect women’s privacy and safety in restrooms, locker rooms, showers, prisons, domestic violence shelters, and other government-controlled spaces, and said it would provide clear, sex-based rules. Opponents, including many transgender Texans, civil rights advocates, clergy, business and public safety voices, and others, argued the bill would invite harassment, gender policing, lawsuits, and invasive inspections, while harming trans, intersex, and gender-nonconforming people as well as cisgender women who do not fit stereotypes. Several witnesses said the bill would conflict with federal law or prison standards, worsen safety in shelters and prisons, and hurt Texas’s reputation and economy. The chair repeatedly noted the compressed special-session schedule and said flood relief remained the session’s top priority. Public testimony on SB 8 was eventually closed, and the bill was left pending. The committee then moved to Senate Bill 6, dealing with consumable hemp product restrictions. Testimony on SB 6 focused on whether the bill went too far in restricting hemp-derived THC products. Opponents argued hemp and THC have medical and economic value, that the bill would criminalize conduct and burden courts, and that regulation—not prohibition—was the better approach. Some witnesses supported tighter rules such as testing, child-resistant packaging, and limits on marketing to children, but still opposed the bill’s broad THC ban, higher fees, and age restrictions. Several speakers emphasized benefits for veterans, chronic pain patients, and small businesses, and warned that prohibition would push consumers toward the illicit market. The committee heard the testimony and then continued with additional witnesses, with no final vote or disposition reported in the excerpt.
TX
Transcript Highlights:
  • has heard on this issue, with mothers coming in, they're real, but they all have to do with fake cannabinoids
  • Y'all, I've never even tried THC or weed or cannabinoid or any weed product.
  • of the population of all cases reported to the National Program on Substance Abuse Deaths had a cannabinoid
NH

New Hampshire 2025 Regular Session

Senate Judiciary (03/25/2025)

Judiciary

Transcript Highlights:
  • THC is the commonly known intoxicating cannabinoid, but there are many non-intoxicating cannabinoids
  • THC is the commonly known intoxicating cannabinoid, but there are many non-intoxicating cannabinoids
  • This bill is very strictly limited to non-intoxicating cannabinoids.
  • Any cannabinoid that we sell, we have to have grown it. Okay.
  • There was a question about the synthetic cannabinoids.
Keywords: 1191, senate, all
TX
Transcript Highlights:
  • SB 3's criminalization of federally legal cannabinoid cannabinoids also poses an irreconcilable conflict
  • There are more than 150 cannabinoids.
  • They want to outlaw hemp-derived cannabinoids.
  • The problem isn't the cannabinoids.
  • I can buy cannabinoid isolates and I can buy cannabinoid extracts from out-of-state suppliers, I can
TX

Texas 89th 1st C.S.

Public Health Aug 13th, 2025

Public Health

Transcript Highlights:
  • And those are your synthetic cannabinoids.
  • And those are your synthetic cannabinoids.
  • , and then synthetic cannabinoids.
  • That's happening in a natural cannabinoid.
  • Also, there's other cannabinoids.
Summary: The House Committee on Public Health heard House Bill 5, a proposal to ban THC products outside the Texas Compassionate Use Program while allowing non-intoxicating CBD and CBG products under tighter regulation. Chair Van Deaver gave a lengthy background on the 2018 federal Farm Bill and Texas’s 2019 hemp law, arguing that the lack of guardrails allowed a large, unregulated THC market to develop. HB 5 would impose licensing fees, product registration, testing and inspection requirements, and restrictions intended to keep products away from children. Invited witnesses from law enforcement strongly supported the bill. Steve Dye of the Texas Police Chiefs Association and Brian Hawthorne of the Sheriffs’ Association of Texas argued that THC consumables are widely mislabeled, often far more potent than advertised, and linked to youth access, impaired driving, and organized crime. Both said regulation would be ineffective and would amount to legalization, while a ban would be easier for officers to enforce. They also emphasized support for the Texas Compassionate Use Program and said medical THC should remain available. Dr. Peter Stout of the Texas Association of Crime Lab Directors and Alice Amelot of Texas DPS testified as resource witnesses about forensic testing. They said current lab resources are already stretched thin, that quantitative testing for THC and related cannabinoids is expensive and time-consuming, and that a ban would simplify enforcement because labs could focus on presence/absence testing rather than concentration. Amelot said DPS labs are neutral on the bill but explained that mislabeled products and inaccurate certificates of analysis are common. Committee members asked about traffic safety, impairment, youth use, and the costs of enforcement and lab testing; witnesses repeatedly said the bill would reduce complexity for law enforcement but that any approach would still require more resources for labs.